Legal & General Group PLC Novo Cure LTD Transaction History
Legal & General Group PLC
- $440 Billion
- Q2 2024
A detailed history of Legal & General Group PLC transactions in Novo Cure LTD stock. As of the latest transaction made, Legal & General Group PLC holds 172,251 shares of NVCR stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
172,251
Previous 169,072
1.88%
Holding current value
$2.69 Million
Previous $2.64 Million
11.66%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
77.2MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$189 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$183 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$174 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$46.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$37.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.64B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...